新加坡:远程医疗公司针对疑似COVID-19病例推出远程会诊
视频咨询的公共费用为$ 7.01美元。
根据新闻稿,总部位于新加坡的远程医疗公司Doctor Anywhere正在为怀疑患有COVID-19的患者开设在线咨询诊所。
COVID-19医疗咨询诊所旨在帮助识别COVID-19的体征和症状,并升级可疑病例,以提供进一步的医疗帮助。对于新加坡,泰国和越南的个人来说,这将是一项全套服务。
在新加坡,用户可以在五分钟内与医生交谈以检查是否有感染的可能性,如有必要,他们将协助救护车在下一个小时内将使用者从家里运送到国家传染病中心(NCID)进行拭子测试。
通过Doctor Anywhere COVID-19医疗咨询诊所进行视频咨询的公共费用为$ 7.01( 10新元)。这不包括医生可能开的处方药。
在泰国和越南,当地的Doctor Anywhere团队将提供帮助,将患者与适当的医疗机构联系起来,以进一步接受医疗护理。
其他国家/地区的用户也可以访问该服务,但只能包括与医生进行视频咨询以识别症状并提供有关后续步骤的建议或从当地药房获取药物的备忘录。
各大型保险公司还与Doctor Anywhere合作,向投保人提供COVID-19医疗咨询诊所作为免费服务。*
Doctor Anywhere rolls out teleconsultation for suspected COVID-19 cases
The public fees for video consultations is at $7.01.
Singapore-based telehealth firm Doctor Anywhere is launching an online advisory clinic for patients who are suspecting to have COVID-19, according to a press release.
The COVID-19 Medical Advisory Clinic aims to help to identify COVID-19 signs and symptoms and escalate suspected cases for further medical assistance. For individuals in Singapore, Thailand and Vietnam, this will be a full suite service.
In Singapore, users can speak to a doctor within five minutes to check the possibility of an infection, in which case they will assist in calling an ambulance to transport the user from home to the National Centre for Infectious Diseases (NCID) in the next hour for a swab test.
Public fees for video consultation via the Doctor Anywhere COVID-19 Medical Advisory Clinic is $7.01 (S$10). This does not include medication that might be prescribed by the doctor.
In Thailand and Vietnam, the local Doctor Anywhere teams will provide assistance to connect the patient to the appropriate healthcare authorities to receive further medical attention.
Users in other countries can also access the service, but can only include video consultation with a doctor to identify symptoms and provide advice on next steps or a memo to obtain medication from a local pharmacy.
Major insurers have also partnered with Doctor Anywhere to offer the COVID-19 Medical Advisory Clinic as a free service to their policyholders.
评论